Sultan Kösen measures 2.51 m. Robert Wadlow reached 2.72 m. These two names consistently come up when discussing the record for male height, but the medical reasons behind these extreme growths, and especially their consequences on the body, remain often misunderstood.
Pituitary Gigantism: The Mechanism That Produces Giants
Before discussing records, it is essential to understand what causes such growth. Gigantism is not a simple genetic variation. It results from a tumor of the pituitary gland, this small gland located at the base of the brain that regulates the production of growth hormone.
When this tumor appears during childhood or adolescence, it causes the gland to release abnormal amounts of growth hormone. The bones lengthen well beyond normal, sometimes for years, as long as the growth plates are not fused.
In Sultan Kösen’s case, this tumor was identified and treated. His growth hormone level is now controlled, which has stabilized his height at 2.51 m. To know precisely how tall the tallest man in the world is, it is necessary to distinguish the current record from the absolute historical record.
For Robert Wadlow, born in 1918, modern endocrinological treatments did not exist. His growth never stopped. At 5 years old, he was already 1.64 m tall. At 12 years old, he measured 2.18 m. He broke the record for the tallest man ever recorded at 19 years old, at 2.58 m, and continued to grow until his death at 22 years old.
Sultan Kösen at 2.51 m: Living Record and Joint Aftereffects
Sultan Kösen, of Turkish nationality, is officially recognized by the Guinness World Records as the tallest living man in the world. His height of 2.51 m has been stabilized since the treatment of his pituitary tumor.
He also holds the record for the largest hands, measuring 27.5 cm in length. This detail is not trivial: it illustrates the overall effect of gigantism on the entire skeleton, not just on stature.
Why Sultan Kösen Has Difficulty Walking
A height like that imposes considerable mechanical constraints. The body’s weight is distributed over joints that were not designed to bear such a load. The knees, hips, and spine undergo accelerated wear.
Articles in pediatric neuroendocrinology remind us that even when growth is medically controlled, the joint and neurological aftereffects remain significant. Sultan Kösen moves with crutches. His rehabilitation is a continuous effort.
- The pituitary tumor causes disproportionate bone growth that weakens the weight-bearing joints
- Hormonal treatment stops growth but does not repair the structural damage already caused to the cartilage and ligaments
- The extremities (hands, feet) often retain record dimensions even after height stabilization
Robert Wadlow: 2.72 m, the Absolute Record Never Matched
Robert Wadlow remains the tallest man in history with a measured height of 2.72 m and a weight of 199 kg. Nicknamed the Giant of Alton (after his hometown in Illinois), he was born on February 22, 1918, and died on July 15, 1940, at just 22 years old.
His growth was rapid from early childhood. Can you imagine a 5-year-old child who surpasses most adults? That was his daily reality, and that of his parents who had to adapt their entire home.
A Death Linked to the Consequences of Gigantism
Robert Wadlow wore leg braces to stabilize his ankles. One of them caused an injury that became infected. His gigantism had altered his nerve sensitivity in the extremities, and he did not feel the wound in time.
This medical detail summarizes the paradox of gigantism: the body grows, but the nervous and circulatory systems do not follow the same curve. The nerve endings, stretched over abnormal distances, transmit pain signals less effectively.
Why Cases of Extreme Gigantism Are Disappearing
A fact often overlooked in articles about height records is that new cases of extreme giants have become extremely rare in countries with advanced pediatric care systems.
The reason is simple. Pituitary tumors are now detected early, often in childhood, thanks to systematic growth assessments. Treatment (surgery, medications regulating growth hormone) occurs before height exceeds extreme thresholds.
- Early screening through pediatric growth charts identifies anomalies in the early years
- Modern endocrinological treatments allow for the control of growth hormone production before the fusion of the growth plates
- In countries with limited access to care, untreated gigantism cases continue to appear, explaining the geographical distribution of recent records
Sultan Kösen, from rural Turkey, was diagnosed late. If his tumor had been detected at 6 years old rather than in adolescence, his final height would likely have been much lower than 2.51 m.
Height Record: Two Measurements, Two Eras
The height record boils down to two figures. 2.72 m for Robert Wadlow, the absolute and historical record. 2.51 m for Sultan Kösen, the record for the living man. The 21 cm gap between the two directly reflects the advances in endocrine medicine over the last century.
These records are not mere anecdotal curiosities. They tell the story of a pathology, pituitary gigantism, and the growing ability of medicine to manage it. The next record holder, if one appears someday, will likely come from a region where access to pediatric diagnosis remains limited.